Literature DB >> 878833

Arrhythmias during halothane anaesthesia II: the influence of atropine.

B Eikard, J R Andersen.   

Abstract

The effect of i.v. atropine premedication on cardiac rhythm was studied in healthy adult patients during thiopental-N2O/O2-halothane anesthesia without intubation. A higher incidnece of arrhythmias was seen in younger patients in close relation to administration of atropine, but the overall incidence during anesthesia was identical in atropine groups and the control groups. The most common arrhythmias were supraventricular ectopies. None of the ECG irregularities led to serious arrhythmias. No consistent changes in blood pressure were observed as the result of arrhythmias or changes in heart rate. It is concluded that atropine should be reserved for situations where severe bradycardia and hypotension occur, or can be expected to occur, and not given automatically, since cardioacceleration which is inherent in its action may be injurious to patients with limited cardiac reserve.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 878833     DOI: 10.1111/j.1399-6576.1977.tb01216.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

Review 1.  Anticholinergic drugs and anaesthesia.

Authors:  R K Mirakhur
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

2.  Comparison of the effects of atropine and glycopyrrolate on various end-organs.

Authors:  R K Mirakhur; J W Dundee
Journal:  J R Soc Med       Date:  1980-10       Impact factor: 5.344

3.  Modification of chronotropic response to anticholinergics by halogenated anaesthetics in children.

Authors:  S K Samra; P J Cohen
Journal:  Can Anaesth Soc J       Date:  1980-11

4.  Does glycopyrrolate premedication facilitate tracheal intubation with a rigid video-stylet?: A randomized controlled trial.

Authors:  Eun-Ah Cho; Sung-Ha Hwang; Sung Hyun Lee; Kyoung-Ho Ryu; Yun-Hong Kim
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.